Type 2 diabetes (T2D) is the most common form of diabetes, accounting for 90–95% of all cases. It is a complex metabolic disease characterized by progressive insulin resistance and eventual relative insulin deficiency. Unlike Type 1, Type 2 diabetes develops gradually and is strongly influenced by lifestyle factors, genetics, and body weight.
What Causes Type 2 Diabetes?
T2D results from a two-part problem:
- Insulin resistance: The body's cells — particularly in muscle, fat, and liver — become less responsive to insulin. The pancreas compensates by producing more insulin.
- Progressive beta cell failure: Over years, the overworked pancreatic beta cells gradually lose their ability to keep up with the demand for extra insulin, leading to rising blood sugars.
Risk factors include obesity (especially central/abdominal fat), physical inactivity, family history of T2D, age over 45, pre-diabetes, gestational diabetes history, and certain ethnicities (Hispanic, Black, Asian, and Native American populations have higher risk).
Complications of Untreated Type 2 Diabetes
Chronically elevated blood sugar damages blood vessels and nerves:
- Cardiovascular disease: Heart attack, stroke, peripheral artery disease
- Nephropathy: Kidney damage leading to chronic kidney disease and eventual dialysis
- Retinopathy: Damage to the blood vessels of the retina, potentially causing blindness
- Neuropathy: Nerve damage causing pain, numbness, and tingling — most commonly in the feet
- Diabetic foot problems: Neuropathy combined with poor circulation can lead to serious foot ulcers and amputations
Treatment Approach
T2D management is multifaceted:
- Lifestyle modification: The foundation. Weight loss (even 5–10% body weight), increased physical activity, and a healthy diet can dramatically improve insulin sensitivity and blood sugar levels. In some cases, lifestyle changes alone can normalize blood sugars.
- Medications: When lifestyle alone is insufficient, medications are added. Metformin remains the first-line oral medication. Many newer classes offer additional benefits.
- Monitoring: Regular A1C testing (every 3–6 months), blood pressure, kidney function, cholesterol, and eye/foot exams.
Key Medication Classes in T2D
| Drug Class | Examples | Key Benefit |
|---|---|---|
| Biguanides | Metformin | Reduces liver glucose production; very safe; first-line |
| GLP-1 Agonists | Ozempic, Victoza, Trulicity, Mounjaro | Lowers A1C, promotes weight loss, cardiovascular benefit |
| SGLT-2 Inhibitors | Jardiance, Farxiga, Invokana | Lowers A1C, reduces heart failure risk and kidney progression |
| DPP-4 Inhibitors | Januvia, Tradjenta | Modest A1C lowering; weight-neutral; well-tolerated |
| Sulfonylureas | Glipizide, Glimepiride | Effective but may cause low blood sugar and weight gain |
| Insulin | Various types | Most powerful glucose-lowering; required in advanced T2D |
💡 Modern T2D Management: GLP-1 receptor agonists (like semaglutide/Ozempic) and SGLT-2 inhibitors have transformed T2D treatment — they lower blood sugar AND reduce the risk of heart attack, heart failure, and kidney disease, making them preferred agents for many patients.
Key Takeaways
- T2D is driven by insulin resistance and progressive beta cell loss
- Obesity, inactivity, and family history are major risk factors
- Lifestyle changes are the foundation of treatment
- Modern medications (GLP-1s, SGLT-2 inhibitors) reduce blood sugar AND heart/kidney risk
- Regular monitoring prevents complications before they become severe